Platelet procoagulant activity: physiological significance and mechanisms of exposure.
about
Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activityInfusible platelet membrane as a platelet substitute for transfusion: an overviewRole of protease-activated and ADP receptor subtypes in thrombin generation on human plateletsExposure of phosphatidylserine on the cell surfaceInfusible platelet membranes improve hemostasis in thrombocytopenic blood: experimental studies under flow conditions.The therapeutic use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.[Thrombocytopathy and blood complications in uremia].Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.Inhibition of platelet activation could decrease thrombotic events in hemodialysis PF4/H antibody-positive patients.In vitro evaluation of the hemostatic effectiveness of non viable platelet preparations: studies with frozen-thawed, sonicated or lyophilized platelets.Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine.Agonist-induced platelet procoagulant activity requires shear and a Rac1-dependent signaling mechanism.Protein C replacement in severe meningococcemia: rationale and clinical experience.Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.A genome-wide linkage scan in German shepherd dogs localizes canine platelet procoagulant deficiency (Scott syndrome) to canine chromosome 27.Plasminogen associates with phosphatidylserine-exposing platelets and contributes to thrombus lysis under flow.The measurement and application of thrombin generation.Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression.The Yin-Yang of thrombin and activated protein C.Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".Scott syndrome erythrocytes contain a membrane protein capable of mediating Ca2+-dependent transbilayer migration of membrane phospholipidsThe fourth epidermal growth factor-like domain of thrombomodulin interacts with the basic exosite of protein C.New antithrombotic strategies for resistant thrombotic processes.The interaction between the endothelial cell protein C receptor and protein C is dictated by the gamma-carboxyglutamic acid domain of protein C.Microvesicle release is associated with extensive protein tyrosine dephosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen.Hepatic and extrahepatic factors critical for liver injury during lipopolysaccharide exposure.Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.Increased platelet phosphatidylserine exposure and caspase activation in chronic uremia.In vitro testing of fresh and lyophilized reconstituted human and baboon platelets.The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.Platelet integrins exhibit anisotropic mechanosensing and harness piconewton forces to mediate platelet aggregation.Prourokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins.Pb(II) Induces Scramblase Activation and Ceramide-Domain Generation in Red Blood Cells.Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects
P2860
Q24673539-5A996D5E-FB8A-4CA6-A44F-F65416C25D4DQ26861577-CFAA3080-EAC7-4825-9A62-348A2ABC6A05Q28257658-E1E9C4CF-0C3F-4974-A178-1C256AF16C58Q28386869-2F5B5A16-AD06-4AD1-B59A-4290F2F2177FQ33334113-E4900331-DA2F-4775-AAF2-4536D823489CQ33367036-09C85B48-1C29-43E5-BCA6-7F1FCA3FF870Q33371562-CBA40A38-1E7A-469B-9EA1-DFE745B0362EQ33404773-EE0A4D42-BF4D-4C81-A217-B2C2332042F7Q33414182-360AF757-601F-43CC-BCFD-F082B101186AQ33500125-BB6B3EC8-0075-429F-8420-15DF244FEE51Q33842909-B7B48E80-BC72-4EB3-8C07-4DCA69C6E382Q34209358-28A65B3F-6472-49A9-BFDE-919A578C39E9Q34219618-33C49DF0-3928-4593-B5DD-95E302FD0096Q34423678-6CF3CE9B-0348-4199-9AA1-646B07B4E9BAQ34724482-35F00CBC-8A7F-4F05-883F-0E7D070C701DQ35450594-BCCB7356-B358-48FF-8E42-D017C85EEE50Q36237649-789F1C3E-2D76-4764-92D0-ED4604697595Q36611294-214B860B-CE01-4342-BC21-D3DEE10B378CQ37084859-337B2834-B6D3-422D-B4D0-402282DB105BQ37358508-0E580787-F588-487D-8786-28438A7140B9Q37366771-459EE438-4CE8-4D11-B3E7-3215BF8458BAQ40677496-933BC9D8-F134-46B4-B9BD-7220011CCEDEQ40727618-527447E6-9024-4C66-AAD0-9B191BC195DAQ41087128-CAB01DF5-69BD-49FC-8005-14E73B3AC464Q41975625-95B230D9-02ED-44B3-B62F-3C6487D1BBE2Q43797527-ADDE19A4-4C6E-4571-B302-686863E428D7Q43980523-D3A3F147-8140-43F4-B5F7-B83BB20A08F7Q45013438-D9A4BA8C-9A3E-4F5D-996C-52A32BAA2B46Q45070700-DD00F9CF-3F3A-4708-9156-08B8EBABEA5EQ45880844-47853654-C9B5-4F3D-91F5-3FD720D5BD1EQ47226792-8591B734-EFB0-4AF6-A028-EAAF000F1F36Q48070607-73F64133-A361-4958-A6C2-ED8797D72BEAQ55054813-F3F9E4C2-6A3F-408B-8A76-ACAD7B9BF2A2Q58717264-0BCCF962-B943-48A6-8334-302C8B243517
P2860
Platelet procoagulant activity: physiological significance and mechanisms of exposure.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Platelet procoagulant activity: physiological significance and mechanisms of exposure.
@en
type
label
Platelet procoagulant activity: physiological significance and mechanisms of exposure.
@en
prefLabel
Platelet procoagulant activity: physiological significance and mechanisms of exposure.
@en
P2093
P1433
P1476
Platelet procoagulant activity: physiological significance and mechanisms of exposure.
@en
P2093
P304
P356
10.1016/0268-960X(91)90031-7
P577
1991-09-01T00:00:00Z